Ihre Region: Deutschland

Referenzen

In absteigender Reihenfolge

1851-1875 von 2795

Produkte Transfektion
Kostenlose Testsamples

Anwendungshinweise:

Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.

Keine Referenz? > Allgemeine Auswahlhilfe

Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.



CELL TYPE DESCRIPTION OF CELL TYPE CAT.NO. SPECIES ORIGIN OF CELLS COMMON CELL TYPE GROWTH PROPERTIES NUCLEIC ACID / DELIVERED MOLECULE APPLICATION PRODUCT REFERENCE TYPE BIBLIOGRAPHIC DATA PDF LINK

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene publication X. Ming et al., Am. Ass. for Cancer Res., 2018, DOI: 10.1158/1541-7786.MCR-18-0070 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al., PLoS ONE, 2019, 14(11): e0224314, doi.org/10.1371/journal.pone.0224314 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene PRO publication D. V. Sorokin et al., Cell Technologies in Biology and Medicine, 2016, 4: 555-559; DOI 10.1007/s10517-016-3217-5

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid cotransfection (plasmid/plasmid) Metafectene PRO publication A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication A.-K. Sommer et al., Oncotarget, 2016, 7 (31): 50461 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene SI publication M. De Luca et al., Scientific Reports, 2021, 11: 4615, doi.org/10.1038/s41598-021-84222- Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid stable transfection Metafectene PRO publication S. E. Semina et al., Cancer Investigation, 2017, DOI: 10.1080/07357907.2017.1368081

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication K. J. Lee et al., Exp. Cell Research, 2015, 336: 211-222; doi.org/10.1016/j.yexcr.2015.07.010

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid stable transfection Metafectene EASY publication K. Haagenson, Dissertation, 2013, Wayne State University Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene PRO publication I. H. Polat et al., Biology, 2021, 10, 85, doi.org/10.3390/biology10020085 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication C. Actis et al., Cancers, 2021, 13: 1252, doi.org/10.3390/cancers13061252 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication A. M. Scherbakov et al., Acta Naturae, 2015, 7(3): 133-1309 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene PRO publication H. Liu et al., J. Lipid Res., Mar 2013; 54: 776 - 785 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication M. S. Herrera, PhD Thesis, 2021, University of Alberta Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al., Breast, 2019, 43, 31e38, https://doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene publication M. R. Graf et al., J. of Cancer Ther. & Res., 2012, doi: 10.7243/2049-7962-1-25 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene PRO publication A. M. Scherbakov et al., Annals of Oncology, 2019, 30: 5, doi.org/10.1093/annonc/mdz269.024 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication H.-K. Lee, PhD Thesis, 2015, Seoul National University Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent oligonucleotide Metafectene publication A. M. Tamaddona et al., Iranian J. of Pharm. Sci., 2011, 11: 7(2): 79-87 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid Metafectene PRO publication S. E. Semina et al., Molecules, 2018, 23: 829; doi:10.3390/molecules23040829 Link

MCF-7

Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference Metafectene PRO publication J. R. Skaar et al., J. Cell Biol., Oct 2009; 187: 25 - 32 Link

In absteigender Reihenfolge

1851-1875 von 2795